NPI: 1629283197 · LOS ANGELES, CA 90027 · Federally Qualified Health Center (FQHC) · NPI assigned 05/10/2007
Authorized official YOUNG, ROBERT controls 20+ related entities in our dataset. Read more
| Authorized Official | YOUNG, ROBERT (VP, PATIENT FINANCIAL SERVICES) |
| NPI Enumeration Date | 05/10/2007 |
Other providers sharing the same authorized official: YOUNG, ROBERT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 113,616 | $35.94M |
| 2019 | 343,969 | $39.36M |
| 2020 | 370,946 | $45.29M |
| 2021 | 447,880 | $51.66M |
| 2022 | 370,763 | $36.74M |
| 2023 | 443,869 | $47.28M |
| 2024 | 415,073 | $49.53M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 718,309 | 655,601 | $298.90M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 52,037 | 39,635 | $723K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 47,287 | 38,251 | $688K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 31,656 | 24,001 | $609K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 27,987 | 16,169 | $592K |
| G9920 | Screening performed and negative | 63,657 | 43,580 | $553K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 8,295 | 7,173 | $412K |
| 90834 | Psychotherapy, 45 minutes with patient | 14,382 | 6,784 | $284K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 14,705 | 13,176 | $266K |
| 92551 | 103,579 | 76,139 | $237K | |
| 90686 | 102,989 | 75,041 | $218K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 7,630 | 4,196 | $162K |
| 0002A | 3,263 | 1,840 | $157K | |
| 90791 | Psychiatric diagnostic evaluation | 4,075 | 2,074 | $128K |
| 0072A | 2,344 | 1,275 | $115K | |
| 0001A | 6,485 | 2,373 | $115K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1,399 | 1,392 | $115K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 449,578 | 265,239 | $111K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 98,371 | 59,611 | $109K |
| 90832 | Psychotherapy, 30 minutes with patient | 7,150 | 3,453 | $89K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 181,922 | 125,648 | $72K |
| 83655 | 11,281 | 9,806 | $71K | |
| 90633 | 10,316 | 9,180 | $65K | |
| 90651 | 12,521 | 10,413 | $62K | |
| 90670 | 13,241 | 11,524 | $58K | |
| 99383 | 1,674 | 1,450 | $55K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 3,572 | 2,531 | $49K |
| 90680 | 5,947 | 5,507 | $46K | |
| 90723 | 5,727 | 5,209 | $40K | |
| 90734 | 5,812 | 5,037 | $39K | |
| 90716 | 3,762 | 3,633 | $36K | |
| 90647 | 6,390 | 5,709 | $35K | |
| 0071A | 2,860 | 1,711 | $34K | |
| 90710 | 4,162 | 3,962 | $32K | |
| 90696 | 3,986 | 3,806 | $32K | |
| 90707 | 3,524 | 3,398 | $32K | |
| 90715 | 3,829 | 3,636 | $30K | |
| 90700 | 3,529 | 3,358 | $29K | |
| 99382 | 977 | 831 | $24K | |
| 99243 | 2,567 | 2,034 | $23K | |
| 85018 | 28,413 | 22,782 | $23K | |
| 90697 | 3,649 | 3,249 | $21K | |
| 99384 | 579 | 487 | $21K | |
| 99381 | 655 | 627 | $20K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 84,943 | 46,352 | $18K |
| 90656 | 8,553 | 6,515 | $18K | |
| 0004A | 350 | 196 | $17K | |
| 0112A | 354 | 340 | $17K | |
| 90461 | 82,386 | 53,968 | $17K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,706 | 1,739 | $12K |
| 90671 | 2,401 | 2,059 | $12K | |
| 90480 | 4,101 | 2,789 | $12K | |
| 90619 | 1,870 | 1,719 | $12K | |
| 90648 | 1,403 | 1,368 | $12K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | 476 | 470 | $12K |
| 90677 | 2,143 | 1,948 | $11K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 5,250 | 3,029 | $9K |
| 0124A | 944 | 663 | $8K | |
| 91321 | 537 | 464 | $7K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,466 | 915 | $7K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 324 | 311 | $6K |
| 91320 | 837 | 678 | $6K | |
| 92015 | Determination of refractive state | 23,480 | 13,735 | $5K |
| 90620 | 526 | 469 | $5K | |
| 90744 | 487 | 481 | $4K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 740 | 593 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 538 | 426 | $3K |
| 0154A | 332 | 251 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1,728 | 1,055 | $3K |
| 91319 | 252 | 222 | $2K | |
| 90713 | 259 | 254 | $2K | |
| 90681 | 302 | 290 | $2K | |
| 99245 | 30 | 15 | $2K | |
| 99173 | 82,156 | 54,481 | $2K | |
| 0074A | 68 | 51 | $2K | |
| G9919 | Screening performed and positive and provision of recommendations | 63 | 62 | $2K |
| 92060 | 9,383 | 5,352 | $2K | |
| 0144A | 39 | 38 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,569 | 1,424 | $1K |
| 90685 | 147 | 147 | $1K | |
| 97802 | 347 | 347 | $1K | |
| 99215 | Prolong outpt/office vis | 1,519 | 1,037 | $1K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 40 | 18 | $995.94 |
| 90732 | 106 | 106 | $936.00 | |
| 91322 | 75 | 68 | $606.84 | |
| 86580 | 305 | 261 | $573.00 | |
| 90381 | 63 | 57 | $567.00 | |
| 90688 | 265 | 184 | $540.72 | |
| G9012 | Other specified case management service not elsewhere classified | 762 | 264 | $276.36 |
| 99000 | 166 | 147 | $265.66 | |
| 99441 | 26 | 25 | $264.16 | |
| 36416 | 1,543 | 1,290 | $262.90 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3,631 | 1,602 | $259.53 |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 3,808 | 3,493 | $173.32 |
| J3490 | Unclassified drugs | 403 | 273 | $165.80 |
| 86756 | 192 | 125 | $145.47 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,134 | 1,315 | $96.81 |
| 93000 | 168 | 145 | $85.23 | |
| 81002 | 469 | 299 | $80.79 | |
| 99242 | 408 | 375 | $50.99 | |
| 3351F | 6,543 | 6,080 | $46.90 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,497 | 2,498 | $35.13 |
| 3074F | 14,511 | 14,120 | $25.77 | |
| 3078F | 14,136 | 13,761 | $25.77 | |
| 88720 | 74 | 54 | $12.54 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 556 | 529 | $8.92 |
| 1126F | 15,899 | 15,462 | $0.30 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 3,175 | 3,076 | $0.00 |
| 0111A | 41 | 27 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 668 | 373 | $0.00 |
| 3008F | 3,746 | 3,735 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 381 | 323 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 975 | 942 | $0.00 |
| 91307 | 2,520 | 1,850 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 430 | 265 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 654 | 311 | $0.00 |
| 0091A | 20 | 12 | $0.00 | |
| 1125F | 330 | 330 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 175 | 98 | $0.00 |
| 91315 | 215 | 142 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 115 | 88 | $0.00 |
| 90474 | 106 | 103 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 208 | 129 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 17 | 13 | $0.00 |
| 99355 | 19 | 13 | $0.00 | |
| 99205 | Prolong outpt/office vis | 20 | 12 | $0.00 |
| 90378 | 30 | 26 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 14 | 14 | $0.00 |
| 90660 | 17 | 15 | $0.00 | |
| 91309 | 21 | 13 | $0.00 | |
| H0033 | Oral medication administration, direct observation | 18 | 12 | $0.00 |
| 91300 | 3,990 | 2,373 | $0.00 | |
| 97803 | 809 | 808 | $0.00 | |
| 1160F | 2,727 | 2,646 | $0.00 | |
| 91311 | 247 | 181 | $0.00 | |
| 1159F | 528 | 502 | $0.00 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 251 | 248 | $0.00 |
| 91312 | 704 | 440 | $0.00 | |
| 90473 | 43 | 43 | $0.00 | |
| 17110 | 18 | 12 | $0.00 | |
| 90736 | 22 | 14 | $0.00 |